Zheng Quan Zhi Xing·2025-08-21 16:35Core Viewpoint - The company has decided to postpone the completion dates of certain fundraising investment projects while maintaining the original investment purposes and scales, ensuring no substantial impact on its operations [4][5][6]. Fundraising Basic Situation - The company issued 30,000,000 A shares at a price of RMB 13.79 per share, raising a total of RMB 413.7 million, with a net amount of RMB 403.62 million after deducting issuance costs [1][2]. Fundraising Usage Situation - As of June 30, 2025, the cumulative investment in the high-end medical equipment construction project is RMB 40.36 million, which is 38,047.16 million of the planned RMB 79.8 million [2][3]. Postponement Details - The planned completion date for the high-end medical equipment and consumables base construction project has been postponed from September 30, 2025, to December 31, 2026 [3][4]. - The headquarters renovation project has also been delayed, with similar adjustments made to its completion timeline [3][4]. Reasons for Postponement - The postponement is due to macroeconomic factors affecting the medical consumables market, leading the company to adjust its production line construction and equipment procurement schedules [3][4]. - The company aims to ensure the stable production of core production lines while optimizing resource allocation [3][4]. Impact of Postponement - The postponement is deemed a prudent decision that will not adversely affect the company's operations or shareholder interests, aligning with the company's strategic development plan [4][5]. - The decision has undergone necessary approval processes and complies with relevant regulations [5][6].